| Lawrence Perlmutter, MD | |
|
35 Hackett Blvd, Albany, NY 12208-3420 | |
| (518) 472-9111 | |
| (518) 449-7210 |
| Full Name | Lawrence Perlmutter |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 54 Years |
| Location | 35 Hackett Blvd, Albany, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326102039 | NPI | - | NPPES |
| 00296846 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 108815 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lawrence Perlmutter Md Pc | 3274790837 | 4 |
News Archive
With a wounded economy and high unemployment, more than 1,000 people came to a one-day free health clinic in the nation's capital Wednesday to get the basic care they can't afford or are otherwise denied because they have no insurance. More than three-quarters of those attending don't have insurance because they are recently unemployed, work for small businesses, earn hourly wages, or must work multiple part-time jobs with no insurance, said the event's medical director Dr. Bobby Kapur.
Cancer researchers at the University of Virginia School of Medicine have identified a key to controlling the growth and progression of prostate cancer, the second most common cancer in men.
Six years from now, when my daughter turns 11, she will get a three-part human papillomavirus vaccine that will reduce her chances of getting cervical cancer by around 70 percent.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.
Premature ovarian failure, also known as primary ovarian insufficiency (POI), affects 1% of all women worldwide. In most cases, the exact cause of the condition, which is often associated with infertility, is difficult to determine.
› Verified 2 days ago
| Entity Name | Lawrence Perlmutter Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508138884 PECOS PAC ID: 3274790837 Enrollment ID: O20120209000162 |
News Archive
With a wounded economy and high unemployment, more than 1,000 people came to a one-day free health clinic in the nation's capital Wednesday to get the basic care they can't afford or are otherwise denied because they have no insurance. More than three-quarters of those attending don't have insurance because they are recently unemployed, work for small businesses, earn hourly wages, or must work multiple part-time jobs with no insurance, said the event's medical director Dr. Bobby Kapur.
Cancer researchers at the University of Virginia School of Medicine have identified a key to controlling the growth and progression of prostate cancer, the second most common cancer in men.
Six years from now, when my daughter turns 11, she will get a three-part human papillomavirus vaccine that will reduce her chances of getting cervical cancer by around 70 percent.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.
Premature ovarian failure, also known as primary ovarian insufficiency (POI), affects 1% of all women worldwide. In most cases, the exact cause of the condition, which is often associated with infertility, is difficult to determine.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lawrence Perlmutter, MD 35 Hackett Blvd, Albany, NY 12208-3420 Ph: (518) 472-9111 | Lawrence Perlmutter, MD 35 Hackett Blvd, Albany, NY 12208-3420 Ph: (518) 472-9111 |
News Archive
With a wounded economy and high unemployment, more than 1,000 people came to a one-day free health clinic in the nation's capital Wednesday to get the basic care they can't afford or are otherwise denied because they have no insurance. More than three-quarters of those attending don't have insurance because they are recently unemployed, work for small businesses, earn hourly wages, or must work multiple part-time jobs with no insurance, said the event's medical director Dr. Bobby Kapur.
Cancer researchers at the University of Virginia School of Medicine have identified a key to controlling the growth and progression of prostate cancer, the second most common cancer in men.
Six years from now, when my daughter turns 11, she will get a three-part human papillomavirus vaccine that will reduce her chances of getting cervical cancer by around 70 percent.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoPatch® SG pulmonary human cardiac patch processed with the Company's proprietary SynerGraft® technology. CryoLife's SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the integrity of the underlying collagen matrix.
Premature ovarian failure, also known as primary ovarian insufficiency (POI), affects 1% of all women worldwide. In most cases, the exact cause of the condition, which is often associated with infertility, is difficult to determine.
› Verified 2 days ago
Lawrence R Marwill, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 23 Hackett Blvd, Albany, NY 12208 Phone: 518-449-5417 Fax: 518-432-0580 | |
Dr. David Henry Perlmutter, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 35 Hackett Blvd, 236, Albany, NY 12208 Phone: 518-472-9111 Fax: 518-449-7210 | |
Victoria Epstein, M.S., D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 63 Shaker Rd Ste 101, Albany, NY 12204 Phone: 518-434-1042 Fax: 518-434-4327 | |
Dr. Robert Anthony Catalano, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 35 Hackett Blvd, Albany, NY 12208 Phone: 518-262-1466 Fax: 518-262-1465 | |
Aaron Kassoff, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 63 Shaker Rd, Suite 101, Albany, NY 12204 Phone: 518-434-1042 Fax: 518-434-4327 | |
Dr. Ashok Sehgal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 63 Shaker Rd, Suite 101, Albany, NY 12204 Phone: 518-434-1042 Fax: 518-434-4327 | |
Dr. Thomas A Bailey, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 222 Great Oaks Blvd, Albany, NY 12203 Phone: 518-452-6002 Fax: 518-452-6078 |